Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Pr.Gr.- PA: Sex/Gend. in Health Res.- Sex/gender sci. health equity pri. Comm.

University of Guelph

$100,000.00

The impact of menopause on ischemia-reperfusion injury and the use of estrogen receptor agonists to protect the heart

FY 2024-25

Summary
Females have lower rates of cardiovascular disease mortality than males early in life. After menopause this trend reverses and women have higher mortality rates. In fact, women who have a heart attack are more likely to die than men. Higher rates of heart attack death for females are partly due to inequities in healthcare access and delivery, but differences remain when these disparities are removed. A barrier in understanding how menopause impacts women's heart attack survival has been the lack of an animal model that mimics the biological changes of menopause. Removal of ovaries from lab animals replicates the decrease in estrogens, but the sudden loss of estrogens mimics how <20% of women enter menopause. Most women undergo a gradual transition called 'perimenopause' which lasts up to a decade. We have a model of menopause in which mice injected with 4-vinylcycloherene diepoxide pass through perimenopause before experiencing the ovarian failure of menopause. We will use this model to investigate how the heart changes across the phases of menopause. We will expose hearts to ischemia to mimic a heart attack and measure molecules that protect the heart against the stress of a heart attack to understand when and how the increased risk of mortality rises in peri- and postmenopause. Estrogens protect against cardiovascular disease in premenopausal women and their loss contributes to the increased risk of cardiovascular mortality after menopause. Chronic estrogen supplementation has unclear benefits for cardiovascular health, but our preliminary data show that a novel treatment in which hearts are acutely exposed to estrogen mimetics after a heart attack limits injury. Whether this clinically viable treatment is effective after menopause has not been tested. We propose to use our mouse models of menopause to determine if acute exposure to estrogenic compounds protects in the postmenopausal environment and identify the molecular mechanisms that provide protection.
Program
Pr.Gr.- PA: Sex/Gend. in Health Res.- Sex/gender sci. health equity pri. Comm.
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
515925
Name
Pyle Glen W
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Biomedical
Prcname2
Gender, Sex &amp; Health
Projecttitle
The impact of menopause on ischemia-reperfusion injury and the use of estrogen receptor agonists to protect the heart
Programtype2
Operating Grants
Orgnameinp2
University of Guelph
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Pr.Gr.- PA: Sex/Gend. in Health Res.- Sex/gender sci. health equity pri. Comm.
Keyworddelim
Estrogen Receptors; Ischemia-Reperfusion Injury; Menopause; Myocardial Infarction
Abstract
Females have lower rates of cardiovascular disease mortality than males early in life. After menopause this trend reverses and women have higher mortality rates. In fact, women who have a heart attack are more likely to die than men. Higher rates of heart attack death for females are partly due to inequities in healthcare access and delivery, but differences remain when these disparities are removed. A barrier in understanding how menopause impacts women's heart attack survival has been the lack of an animal model that mimics the biological changes of menopause. Removal of ovaries from lab animals replicates the decrease in estrogens, but the sudden loss of estrogens mimics how <20% of women enter menopause. Most women undergo a gradual transition called 'perimenopause' which lasts up to a decade. We have a model of menopause in which mice injected with 4-vinylcycloherene diepoxide pass through perimenopause before experiencing the ovarian failure of menopause. We will use this model to investigate how the heart changes across the phases of menopause. We will expose hearts to ischemia to mimic a heart attack and measure molecules that protect the heart against the stress of a heart attack to understand when and how the increased risk of mortality rises in peri- and postmenopause. Estrogens protect against cardiovascular disease in premenopausal women and their loss contributes to the increased risk of cardiovascular mortality after menopause. Chronic estrogen supplementation has unclear benefits for cardiovascular health, but our preliminary data show that a novel treatment in which hearts are acutely exposed to estrogen mimetics after a heart attack limits injury. Whether this clinically viable treatment is effective after menopause has not been tested. We propose to use our mouse models of menopause to determine if acute exposure to estrogenic compounds protects in the postmenopausal environment and identify the molecular mechanisms that provide protection.
Competitiondate
202409
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pyle, Glen W
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
University of Guelph - $100,000 Grant (2024-25) | Canada Spends